GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » Cyclically Adjusted Price-to-FCF

Neurologix (Neurologix) Cyclically Adjusted Price-to-FCF : (As of May. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Neurologix Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Neurologix Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Neurologix's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix Cyclically Adjusted Price-to-FCF Chart

Neurologix Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neurologix Quarterly Data
Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Neurologix's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Neurologix's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurologix's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurologix's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Neurologix's Cyclically Adjusted Price-to-FCF falls into.



Neurologix Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Neurologix's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2011 is calculated as:

For example, Neurologix's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2011 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2011 (Change)*Current CPI (Jun. 2011)
=-0.071/95.2345*95.2345
=-0.071

Current CPI (Jun. 2011) = 95.2345.

Neurologix Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200109 -0.521 75.227 -0.660
200112 -0.178 74.552 -0.227
200203 -0.100 75.438 -0.126
200206 -0.183 75.902 -0.230
200209 -0.119 76.366 -0.148
200212 -0.084 76.324 -0.105
200303 -0.041 77.716 -0.050
200306 -0.051 77.505 -0.063
200309 -0.101 78.138 -0.123
200312 -0.062 77.758 -0.076
200403 -0.046 79.066 -0.055
200406 -0.044 80.037 -0.052
200409 -0.025 80.121 -0.030
200412 -0.028 80.290 -0.033
200503 -0.023 81.555 -0.027
200506 -0.055 82.062 -0.064
200509 -0.026 83.876 -0.030
200512 -0.044 83.032 -0.050
200603 -0.028 84.298 -0.032
200606 -0.047 85.606 -0.052
200609 -0.075 85.606 -0.083
200612 -0.044 85.142 -0.049
200703 -0.044 86.640 -0.048
200706 -0.063 87.906 -0.068
200709 -0.055 87.964 -0.060
200712 -0.052 88.616 -0.056
200803 -0.079 90.090 -0.084
200806 -0.049 92.320 -0.051
200809 -0.054 92.307 -0.056
200812 -0.042 88.697 -0.045
200903 -0.073 89.744 -0.077
200906 -0.077 91.003 -0.081
200909 -0.106 91.120 -0.111
200912 -0.077 91.111 -0.080
201003 -0.113 91.821 -0.117
201006 -0.071 91.962 -0.074
201009 -0.054 92.162 -0.056
201012 -0.054 92.474 -0.056
201103 -0.094 94.283 -0.095
201106 -0.071 95.235 -0.071

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Neurologix  (GREY:NRGXQ) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Neurologix Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Neurologix's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurologix (Neurologix) Business Description

Industry
Traded in Other Exchanges
N/A
Address
One Bridge Plaza, Fort Lee, NJ, USA, 07024
Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines